Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Eisai and Arena complete registrational studies of extended-release lorcaserin

April 13, 2015

DiscoveryBioMed receives NIH grant to discover adiponectin secretion stimulators

April 13, 2015

LXRbeta partial agonist shows potential for the treatment of atherosclerosis

April 13, 2015

AstraZeneca selects first microRNA from Regulus Therapeutics alliance for clinical development

April 10, 2015

FDA accepts ArmaGen's IND application for Hurler syndrome therapy

April 9, 2015

European orphan drug designation for Trappsol Cyclo transferred to MNE

April 9, 2015

Repros' enclomiphene eligible for new active substance status

April 8, 2015

Natpara now available in the U.S.

April 7, 2015

Identification of novel spiro-hydantoins as SARMs

April 7, 2015

Kowa discloses PCSK9 mRNA expression inhibitors

April 2, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026